GXI Stock Overview
Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Gerresheimer AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €70.15 |
| 52 Week High | €111.20 |
| 52 Week Low | €69.70 |
| Beta | 0.92 |
| 11 Month Change | -17.28% |
| 3 Month Change | -27.94% |
| 1 Year Change | -17.13% |
| 33 Year Change | -10.98% |
| 5 Year Change | 3.24% |
| Change since IPO | 82.92% |
Recent News & Updates
Gerresheimer AG Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next
Oct 03
Is Gerresheimer (ETR:GXI) Using Too Much Debt?
Sep 29Gerresheimer AG's (ETR:GXI) Share Price Matching Investor Opinion
Aug 31Recent updates
Gerresheimer AG Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next
Oct 03Is Gerresheimer (ETR:GXI) Using Too Much Debt?
Sep 29Gerresheimer AG's (ETR:GXI) Share Price Matching Investor Opinion
Aug 31Shareholders Will Most Likely Find Gerresheimer AG's (ETR:GXI) CEO Compensation Acceptable
May 30Gerresheimer AG's (ETR:GXI) Share Price Matching Investor Opinion
May 22An Intrinsic Calculation For Gerresheimer AG (ETR:GXI) Suggests It's 40% Undervalued
May 03Analysts Are Updating Their Gerresheimer AG (ETR:GXI) Estimates After Its First-Quarter Results
Apr 14Gerresheimer's (ETR:GXI) Dividend Will Be €1.25
Apr 12Gerresheimer (ETR:GXI) Has A Somewhat Strained Balance Sheet
Apr 10Gerresheimer (ETR:GXI) Has Announced A Dividend Of €1.25
Feb 25Investors Still Waiting For A Pull Back In Gerresheimer AG (ETR:GXI)
Feb 10At €92.85, Is Gerresheimer AG (ETR:GXI) Worth Looking At Closely?
Jan 23Are Investors Undervaluing Gerresheimer AG (ETR:GXI) By 28%?
Jan 03Is Gerresheimer (ETR:GXI) Using Too Much Debt?
Dec 15When Should You Buy Gerresheimer AG (ETR:GXI)?
Oct 19An Intrinsic Calculation For Gerresheimer AG (ETR:GXI) Suggests It's 42% Undervalued
Oct 01Is Gerresheimer (ETR:GXI) Using Too Much Debt?
Aug 26Should You Investigate Gerresheimer AG (ETR:GXI) At €105?
Jul 06Gerresheimer AG's (ETR:GXI) Intrinsic Value Is Potentially 94% Above Its Share Price
Jun 18Gerresheimer (ETR:GXI) Is Paying Out A Dividend Of €1.25
Apr 05Is Gerresheimer (ETR:GXI) A Risky Investment?
Mar 17Gerresheimer's (ETR:GXI) Dividend Will Be €1.25
Feb 27What Does Gerresheimer AG's (ETR:GXI) Share Price Indicate?
Feb 15Is Gerresheimer (ETR:GXI) Using Too Much Debt?
Nov 18Is Now An Opportune Moment To Examine Gerresheimer AG (ETR:GXI)?
Sep 06Is Gerresheimer (ETR:GXI) A Risky Investment?
Aug 18Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25
May 31Gerresheimer (ETR:GXI) Will Pay A Dividend Of €1.25
May 16Gerresheimer (ETR:GXI) Has Announced A Dividend Of €1.25
May 02Gerresheimer (ETR:GXI) Has Affirmed Its Dividend Of €1.25
Apr 18Gerresheimer (ETR:GXI) Has Affirmed Its Dividend Of €1.25
Apr 04Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25
Mar 21Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25
Mar 06Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25
Feb 20At €72.85, Is Gerresheimer AG (ETR:GXI) Worth Looking At Closely?
Feb 17Is Gerresheimer (ETR:GXI) A Risky Investment?
Jan 06What Does Gerresheimer AG's (ETR:GXI) Share Price Indicate?
Nov 04Does Gerresheimer (ETR:GXI) Have A Healthy Balance Sheet?
Sep 23Is Gerresheimer AG (ETR:GXI) Trading At A 24% Discount?
Sep 05Should You Think About Buying Gerresheimer AG (ETR:GXI) Now?
Jul 11Is Gerresheimer (ETR:GXI) A Risky Investment?
Jun 24Shareholder Returns
| GXI | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | -5.4% | -6.0% | -0.4% |
| 1Y | -17.1% | 1.4% | 7.1% |
Return vs Industry: GXI underperformed the German Life Sciences industry which returned 1.6% over the past year.
Return vs Market: GXI underperformed the German Market which returned 7.8% over the past year.
Price Volatility
| GXI volatility | |
|---|---|
| GXI Average Weekly Movement | 6.5% |
| Life Sciences Industry Average Movement | 6.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: GXI has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: GXI's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1864 | 12,012 | Dietmar Siemssen | www.gerresheimer.com |
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Gerresheimer AG Fundamentals Summary
| GXI fundamental statistics | |
|---|---|
| Market cap | €2.42b |
| Earnings (TTM) | €114.30m |
| Revenue (TTM) | €2.01b |
21.2x
P/E Ratio1.2x
P/S RatioIs GXI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GXI income statement (TTM) | |
|---|---|
| Revenue | €2.01b |
| Cost of Revenue | €1.43b |
| Gross Profit | €585.40m |
| Other Expenses | €471.10m |
| Earnings | €114.30m |
Last Reported Earnings
Aug 31, 2024
Next Earnings Date
Feb 26, 2025
| Earnings per share (EPS) | 3.31 |
| Gross Margin | 29.09% |
| Net Profit Margin | 5.68% |
| Debt/Equity Ratio | 81.7% |
How did GXI perform over the long term?
See historical performance and comparison